Figure 2.
Survival curves showing the progression-free survival (PFS) of lung adenocarcinoma patients with and without detectable epidermal growth factor receptor (EGFR) mutations in plasma circulating tumor DNA (ctDNA) by ARMS.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.